T1	Participants 68 115	diabetic patients after amputation for gangrene
T2	Participants 357 459	231 non-insulin-dependent diabetic men with either a recent amputation for gangrene or active gangrene
T3	Participants 585 694	There were 24 atherosclerotic deaths in the drug treatment group (21.8%) and 23 in the placebo group (19.0%).
